$30.25
+0.050%Sila Realty Trust, Inc. is a net lease real estate investment trust headquartered in Tampa, Florida, with a strategic focus on investing in the significant, growing, and resilient healthcare sector of the U.S. economy. The Company invests in high quality healthcare facilities along the continuum of care, which, we believe, generate predictable, durable, and growing income streams. Our portfolio is comprised of high quality tenants in geographically diverse facilities which are positioned to capitalize on the dynamic delivery of healthcare to patients. As of December 31, 2023, the Company owned 131 real estate properties and two undeveloped land parcels located in 62 markets across the United States.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Outstanding operational efficiency. The company generates substantial profit from core operations.
Strong net margins indicate efficient operations and favorable tax/interest management.
Below-average tax rate suggests effective tax planning, favorable jurisdictions, or tax credits.
Exceptional profitability across all levels: Strong pricing power, efficient operations, and healthy bottom line indicate a high-quality business with sustainable competitive advantages.
SILA • NYSE
| Sila Realty Trust, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||
197.5M | 186.9M | 189.1M | 180M | 172.8M | 165.8M | 101.2M | 177.3M | 125.1M | 56.4M | |
GROSS PROFIT | ||||||||||
(23.8M) | (23.1M) | (20.2M) | (18M) | (17.7M) | (16.4M) | (10.7M) | (104.4M) | (77.2M) | (32.3M) | |
173.7M | 163.7M | 168.9M | 162M | 155.1M | 149.4M | 90.5M | 72.9M | 47.9M | 24.1M | |
OPERATING INCOME | ||||||||||
(108.8M) | (103.1M) | (98.2M) | (99.3M) | (119.4M) | (57M) | (78.7M) | -33.7M | -22.7M | -9.6M | |
(20.9M) | (25.3M) | (23.9M) | (22.1M) | (21.4M) | (28.1M) | (17.8M) | (0.0) | (0.0) | (0.0) | |
64.9M | 60.6M | 70.7M | 62.8M | 35.7M | 92.4M | 11.8M | 54M | 41.1M | 19.2M | |
PRE-TAX INCOME | ||||||||||
(32.8M) | (21.2M) | (23.1M) | (24.1M) | (37.6M) | (0.0) | (33.6M) | (34.4M) | (0.0) | (0.0) | |
-32.8M | -17.1M | -22.4M | -23.8M | -34.5M | 2M | -33.6M | -34.4M | 22.5M | 4.4M | |
(87.9M) | (77.8M) | (74.3M) | (77.2M) | (98M) | (28.9M) | (60.9M) | -33.7M | -22.8M | -9.6M | |
-31.8M | -18M | -46.6M | -70.7M | -34.5M | -83.5M | -33.6M | -34.4M | 41.2M | 19.2M | |
33.1M | 42.7M | 24M | -8M | 1.2M | 8.9M | -21.8M | 121.5M | 85M | 40.2M | |
NET INCOME | ||||||||||
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (67.5M) | (43.9M) | (21M) | |
33.1M | 42.7M | 24M | -8M | 402.7M | 36.8M | 2.8M | 33.8M | 21.1M | 11.4M |
SILA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 20, 2026 | April 19, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 24, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 04, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 30, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 08, 2025 | September 08, 2025 | 2025 |
Continue your SILA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.